MX9206093A - Derivado de oxazolidona - Google Patents
Derivado de oxazolidonaInfo
- Publication number
- MX9206093A MX9206093A MX9206093A MX9206093A MX9206093A MX 9206093 A MX9206093 A MX 9206093A MX 9206093 A MX9206093 A MX 9206093A MX 9206093 A MX9206093 A MX 9206093A MX 9206093 A MX9206093 A MX 9206093A
- Authority
- MX
- Mexico
- Prior art keywords
- represent
- formula
- group
- hydrogen
- nitrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D263/57—Aryl or substituted aryl radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27552691 | 1991-10-23 | ||
| JP4236642A JP2669579B2 (ja) | 1991-10-23 | 1992-09-04 | オキサゾリドン誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9206093A true MX9206093A (es) | 1993-04-01 |
Family
ID=26532773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9206093A MX9206093A (es) | 1991-10-23 | 1992-10-22 | Derivado de oxazolidona |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5475014A (es) |
| EP (1) | EP0609441B1 (es) |
| JP (1) | JP2669579B2 (es) |
| KR (2) | KR970011283B1 (es) |
| CN (2) | CN1031619C (es) |
| AT (1) | ATE182331T1 (es) |
| AU (1) | AU658227B2 (es) |
| CA (1) | CA2116337A1 (es) |
| DE (1) | DE69229637T2 (es) |
| FI (1) | FI941863A (es) |
| HU (1) | HUT70548A (es) |
| MX (1) | MX9206093A (es) |
| NO (1) | NO304486B1 (es) |
| NZ (1) | NZ244847A (es) |
| PH (1) | PH30210A (es) |
| TW (1) | TW307766B (es) |
| WO (1) | WO1993008179A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4425609A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | Benzofuranyl- und Benzothienyloxazolidinone |
| DE19514313A1 (de) | 1994-08-03 | 1996-02-08 | Bayer Ag | Benzoxazolyl- und Benzothiazolyloxazolidinone |
| HRP960159A2 (en) * | 1995-04-21 | 1997-08-31 | Bayer Ag | Benzocyclopentane oxazolidinones containing heteroatoms |
| DE19601265A1 (de) * | 1996-01-16 | 1997-07-17 | Bayer Ag | 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone |
| DE19601264A1 (de) * | 1996-01-16 | 1997-07-17 | Bayer Ag | Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone |
| DE19601627A1 (de) | 1996-01-18 | 1997-07-24 | Bayer Ag | Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone |
| HRP970049A2 (en) * | 1996-02-06 | 1998-04-30 | Bayer Ag | New heteroaryl oxazolidinones |
| DE19604223A1 (de) * | 1996-02-06 | 1997-08-07 | Bayer Ag | Neue substituierte Oxazolidinone |
| US6083967A (en) * | 1997-12-05 | 2000-07-04 | Pharmacia & Upjohn Company | S-oxide and S,S-dioxide tetrahydrothiopyran phenyloxazolidinones |
| EP1382603B1 (en) | 2001-04-26 | 2008-07-23 | Eisai R&D Management Co., Ltd. | Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof |
| TW200302095A (en) * | 2002-01-25 | 2003-08-01 | Upjohn Co | Oxazolidinone cotherapy |
| US7094790B2 (en) | 2003-05-07 | 2006-08-22 | Abbott Laboratories | Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| TW200519105A (en) * | 2003-10-20 | 2005-06-16 | Lg Life Science Ltd | Novel inhibitors of DPP-IV, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent |
| JP4634720B2 (ja) * | 2004-01-20 | 2011-02-16 | サントリーホールディングス株式会社 | ガス検出方法および検出装置 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1171865A (en) * | 1980-06-04 | 1984-07-31 | Alain Lacour | N-aryl azolone derivatives, the process for preparing the same and their application in therapeutics |
| US4801600A (en) * | 1987-10-09 | 1989-01-31 | E. I. Du Pont De Nemours And Company | Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents |
| US5322835A (en) * | 1988-04-20 | 1994-06-21 | Sumitomo Chemical Company, Limited | N-phenylimides, and their production and use |
-
1992
- 1992-09-04 JP JP4236642A patent/JP2669579B2/ja not_active Expired - Fee Related
- 1992-09-30 AU AU26927/92A patent/AU658227B2/en not_active Ceased
- 1992-09-30 DE DE69229637T patent/DE69229637T2/de not_active Expired - Fee Related
- 1992-09-30 AT AT92920700T patent/ATE182331T1/de not_active IP Right Cessation
- 1992-09-30 KR KR1019940700897A patent/KR970011283B1/ko active
- 1992-09-30 HU HU9401161A patent/HUT70548A/hu unknown
- 1992-09-30 EP EP92920700A patent/EP0609441B1/en not_active Expired - Lifetime
- 1992-09-30 CA CA002116337A patent/CA2116337A1/en not_active Abandoned
- 1992-09-30 WO PCT/JP1992/001257 patent/WO1993008179A1/ja active IP Right Grant
- 1992-09-30 KR KR1019940700897A patent/KR940702491A/ko not_active IP Right Cessation
- 1992-10-07 PH PH45052A patent/PH30210A/en unknown
- 1992-10-09 TW TW081108039A patent/TW307766B/zh active
- 1992-10-21 NZ NZ244847A patent/NZ244847A/en unknown
- 1992-10-22 MX MX9206093A patent/MX9206093A/es not_active IP Right Cessation
- 1992-10-22 CN CN92112329A patent/CN1031619C/zh not_active Expired - Lifetime
-
1994
- 1994-03-08 US US08/204,326 patent/US5475014A/en not_active Expired - Lifetime
- 1994-04-21 NO NO941451A patent/NO304486B1/no unknown
- 1994-04-21 FI FI941863A patent/FI941863A/fi unknown
-
1995
- 1995-04-28 CN CN95104597A patent/CN1113240A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0609441B1 (en) | 1999-07-21 |
| AU2692792A (en) | 1993-05-21 |
| JPH05194440A (ja) | 1993-08-03 |
| CN1071665A (zh) | 1993-05-05 |
| WO1993008179A1 (en) | 1993-04-29 |
| CN1113240A (zh) | 1995-12-13 |
| JP2669579B2 (ja) | 1997-10-29 |
| CN1031619C (zh) | 1996-04-24 |
| KR970011283B1 (ko) | 1997-07-09 |
| EP0609441A1 (en) | 1994-08-10 |
| NO941451L (es) | 1994-06-22 |
| NO941451D0 (no) | 1994-04-21 |
| HU9401161D0 (en) | 1994-07-28 |
| EP0609441A4 (en) | 1994-08-17 |
| NZ244847A (en) | 1994-09-27 |
| TW307766B (es) | 1997-06-11 |
| DE69229637D1 (de) | 1999-08-26 |
| FI941863A0 (fi) | 1994-04-21 |
| AU658227B2 (en) | 1995-04-06 |
| DE69229637T2 (de) | 1999-12-09 |
| ATE182331T1 (de) | 1999-08-15 |
| FI941863A (fi) | 1994-04-21 |
| PH30210A (en) | 1997-02-05 |
| CA2116337A1 (en) | 1993-04-29 |
| NO304486B1 (no) | 1998-12-28 |
| US5475014A (en) | 1995-12-12 |
| HUT70548A (en) | 1995-10-30 |
| KR940702491A (ko) | 1994-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO933376L (no) | Morfinan-derivater og medisinsk anvendelse derav | |
| KR950701911A (ko) | 피페리딘 유도체를 유효성분으로 하는 말초혈관확장제(peripheral vaso-dilating agent containing piperidine derivative as active ingredient) | |
| LU91210I2 (fr) | Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER) | |
| MX9206093A (es) | Derivado de oxazolidona | |
| FR2684103B1 (fr) | Nouveaux composes a structure guanidique et composition pharmaceutique les contenant. | |
| DE69001722T2 (de) | Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt. | |
| HU9503090D0 (en) | Novel bisoxadiazolidine derivative | |
| ATE86866T1 (de) | Antikrebs-zusammensetzung. | |
| EP0546177A4 (en) | BENZOPYRANE DERIVATIVE, PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME. | |
| DK0420224T3 (da) | Anthihepatopatisk middel | |
| IT1216104B (it) | Peptidi ad attivita' farmaceutica. | |
| ATE205209T1 (de) | Chinolincarbonsäurederivate und ihre salze | |
| KR890012973A (ko) | 이미다졸 유도체 | |
| DK360388A (da) | Laegemiddel til behandling af hjerteinsufficiens | |
| ATE81466T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz. | |
| IT1216103B (it) | Peptidi ad attivita' farmaceutica. | |
| ATE44741T1 (de) | 2-(n-substituierte guanidino)-4heteroarylthiazole als mittel gegen geschwuere. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |